Walking Breaks for Cardiometabolic Health
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine the optimal frequency and duration of walking breaks to improve heart and metabolic health. Researchers will examine how varying lengths and frequencies of walking breaks can reduce blood pressure and glucose levels in individuals who sit for extended periods. Participants will be monitored in a controlled setting to identify the most effective break patterns that do not cause excessive fatigue or discomfort. The trial seeks adults who are generally healthy but may have controlled high blood pressure or cholesterol and are not taking medication for diabetes. As an unphased study, this trial provides participants the chance to contribute to valuable research that could enhance public health guidelines.
Will I have to stop taking my current medications?
The trial requires that participants do not take medication to control blood pressure or glucose, so you may need to stop these medications to participate.
What prior data suggests that these sedentary break protocols are safe?
Research has shown that taking regular walking breaks from sitting is safe and beneficial for health. Studies indicate that interrupting long periods of sitting with walking can lower the risk of heart disease and other health issues, as prolonged sitting is known to increase these risks.
Walking breaks improve blood flow and overall heart health. Although studies have not identified serious safety concerns with walking breaks, finding the right balance is crucial. Excessive exercise can lead to fatigue or discomfort, and this study aims to determine the optimal amount.
In summary, walking breaks are a safe and effective way to enhance heart health, provided they are not overdone. Participants in this study will help identify the ideal amount of walking needed to achieve health benefits without causing discomfort.12345Why are researchers excited about this trial?
Researchers are excited about the Walking Breaks for Cardiometabolic Health trial because it explores a simple, non-invasive approach to improving health. Unlike standard treatments for cardiometabolic issues, which often involve medications like statins or lifestyle advice that can be hard to follow, this trial investigates the potential benefits of regular, short walking breaks. The focus is on how breaking up long periods of sitting with walking can impact heart rate and blood pressure, offering a potentially easy and accessible way to enhance cardiovascular health. This trial could reveal that small changes in daily habits can lead to significant health benefits, making it a promising area of study.
What evidence suggests that sedentary breaks might be effective for cardiometabolic health?
Research shows that taking short walking breaks during long periods of sitting can improve heart and overall health. In this trial, participants will experience both the Sedentary Break (Walking) Condition and the Sitting (Control) Condition. Studies indicate that these breaks can help lower blood pressure and improve cholesterol levels. For example, one study found that taking a four-minute walk every hour reduced bad cholesterol in young adults. Other research has linked excessive sitting to higher risks of heart disease and death. This suggests that even brief, regular movement benefits heart health. Overall, these findings support the idea that short walking breaks can enhance heart and metabolic health.16789
Who Is on the Research Team?
Keith Diaz, PhD
Principal Investigator
Florence Irving Assistant Professor of Behavioral Medicine, CUIMC
Ying Kuen (Ken) Cheung, PhD
Principal Investigator
Professor of Biostatistics, Department of Biostatistics, CUIMC
Are You a Good Fit for This Trial?
This trial is for adults who can understand English or Spanish, have no chronic conditions like heart disease or diabetes, don't take blood pressure or glucose medication, and have no musculoskeletal issues. Participants should not be allergic to common foods, follow specific diets, smoke cigarettes, or have trouble with IV access.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Experimental Condition
Participants undergo two 8-hour lab visits, one with sedentary breaks and one as a control condition, to determine the minimally effective and maximally tolerated doses of sedentary breaks.
Follow-up
Participants are monitored for safety and effectiveness after the experimental conditions.
What Are the Treatments Tested in This Trial?
Interventions
- Controlled Diet
- Sedentary Break (Walking) Condition
- Sitting (Control) Condition
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator